Spinal manifestations of Neurofibromatosis type 1

被引:6
|
作者
Shofty, Ben [1 ,2 ,3 ]
Barzilai, Ori [4 ]
Khashan, Morsi [1 ,2 ]
Lidar, Zvi [1 ,2 ]
Constantini, Shlomi [2 ,3 ,5 ]
机构
[1] Tel Aviv Med Ctr & Sch Med, Dept Neurosurg, Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv, Israel
[3] Gilbert Israeli Int Neurofibromatosis Ctr GIINFC, Tel Aviv, Israel
[4] Mem Sloan Kettering Canc Ctr, Dept Neurol Surg, 1275 York Ave, New York, NY 10021 USA
[5] Tel Aviv Med Ctr & Sch Med, Dana Childrens Hosp, Dept Pediat Neurosurg, Tel Aviv, Israel
关键词
NF1; Spine; Neurofibroma; Plexiform; MEK; NERVE SHEATH TUMORS; PLEXIFORM NEUROFIBROMAS; CORD TUMORS; SURGICAL-MANAGEMENT; DIAGNOSIS; CHILDREN; BURDEN; MRI; TRANSFORMATION; DEFORMITIES;
D O I
10.1007/s00381-020-04754-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Neurofibromatosis type 1 (NF1) patients may present a wide spectrum of spinal pathologies. Osseous changes may lead to severe deformities with significant implications on growth and quality of life. Neurogenic tumors and soft tissue abnormalities may cause neuropathic pain and dysfunction ranging from minor paresthesias to profound motor and sensory deficits. Advanced imaging such as whole-body MRI, and volumetric tumor burden assessment have an evolving role in the evaluation and follow-up of patients with high spinal tumor load. Novel biological agents that target the hyperactivated ras pathway are currently under investigation and are reshaping current and future treatment paradigms. Surgical interventions for benign and malignant tumors, as well as deformity correction remain pivotal in treatment frameworks and require careful assessment by a dedicated multidisciplinary team. Purpose In this manuscript we review the various spinal manifestations of NF1 patients, indication for surgical intervention and oncological treatments.
引用
收藏
页码:2401 / 2408
页数:8
相关论文
共 50 条
  • [1] Spinal manifestations of Neurofibromatosis type 1
    Ben Shofty
    Ori Barzilai
    Morsi Khashan
    Zvi Lidar
    Shlomi Constantini
    [J]. Child's Nervous System, 2020, 36 : 2401 - 2408
  • [2] Neurofibromatosis type 1 - Spinal manifestations of a systemic disease
    Restrepo, CS
    Riascos, RF
    Hatta, AA
    Rojas, R
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2005, 29 (04) : 532 - 539
  • [3] Musculoskeletal Manifestations of Neurofibromatosis Type 1
    Patel, Neel B.
    Stacy, Gregory Scott
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (01) : W99 - W106
  • [4] Ophthalmic manifestations in neurofibromatosis type 1
    Kinori, Michael
    Hodgson, Nickisa
    Zeid, Janice Lasky
    [J]. SURVEY OF OPHTHALMOLOGY, 2018, 63 (04) : 518 - 533
  • [5] Orthopaedic Manifestations of Neurofibromatosis Type 1
    Feldman, David S.
    Jordan, Charles
    Fonseca, Lauren
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2010, 18 (06) : 346 - 357
  • [6] Manifestations of the tongue in Neurofibromatosis type 1
    Bongiorno, MR
    Pistone, G
    Aricò, M
    [J]. ORAL DISEASES, 2006, 12 (02) : 125 - 129
  • [7] Cutaneous manifestations in neurofibromatosis type 1
    Miraglia, E.
    Moliterni, E.
    Lacovino, C.
    Roberti, V
    Laghi, A.
    Moramarco, A.
    Giustini, S.
    [J]. CLINICA TERAPEUTICA, 2020, 171 (05): : E371 - E377
  • [8] Bone Manifestations of Neurofibromatosis Type 1
    Diallo, Ibrahima Dokal
    Iraqi Houssaini, Zaynab
    Tantaoui, Mehdi
    Traore, Wend-Yam Mohamed
    Onka, Behyamet
    El Haddad, Siham
    Chat, Latifa
    Allali, Nazik
    [J]. GLOBAL PEDIATRIC HEALTH, 2022, 9
  • [9] Neurofibromatosis type 1 and cardiac manifestations
    Incecik, Faruk
    Herguner, Ozlem M.
    Erdem, Sevcan Alinc
    Altunbasak, Sakir
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2015, 43 (08): : 714 - 716
  • [10] Renal manifestations in children with neurofibromatosis type 1
    Binnaz Celik
    Ozlem Yuksel Aksoy
    Funda Bastug
    Hatice Gamze Poyrazoglu
    [J]. European Journal of Pediatrics, 2021, 180 : 3477 - 3482